Accelerating Progress in Pediatric Cancer
NCI is pushing the “bench to bedside” paradigm to bring medical advances into the clinic.
Pediatric cancers are considered rare diseases, which makes them more challenging to study and treat. However, efforts like the Childhood Cancer Data Initiative are helping to further disease biology understanding and open pathways for community collaboration. In light of Childhood Cancer Awareness Month, NCI experts discuss the future of advancements such as precision medicine and immunotherapy.
-
Dr. Nirali Shah Hematologic Malignancies Section Head, Pediatric Oncology NCI -
Dr. Christine Heske Translational Sarcoma Biology Group Head, Pediatric Oncology NCI
-
Securing the Future of Open Source Software
Jack Cable and Remy DeCausemaker explore how CISA and CMS are tackling open source software (OSS) security in government.
4m listen -
How AI Will Continue to Advance Biometric Tech
At Identity Week, Arun Vemury discussed how error rates in facial recognition have dropped over the past decade thanks to machine learning.
12m listen -
TSA is Innovating Digital Identity Solutions with AI
At Identity Week, Jason Lim talked about the ways that digital identity is changing the way people travel securely.
10m listen -
The Security and UX Standards That Power Digital Identity Programs
Live from Identity Week, Ryan Galluzzo discusses the latest draft of NIST's Digital Identity Guidelines for the identity-proofing process.
18m listen
